These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32598882)

  • 1. Structural Integrity of the Alveolar-Capillary Barrier in Cynomolgus Monkeys Challenged with Fully Virulent and Toxin-Deficient Strains of Bacillus anthracis.
    D'Agnillo F; Zhang X; Williams MC
    Am J Pathol; 2020 Oct; 190(10):2095-2110. PubMed ID: 32598882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lethal factor, but not edema factor, is required to cause fatal anthrax in cynomolgus macaques after pulmonary spore challenge.
    Hutt JA; Lovchik JA; Drysdale M; Sherwood RL; Brasel T; Lipscomb MF; Lyons CR
    Am J Pathol; 2014 Dec; 184(12):3205-16. PubMed ID: 25285720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacillus anthracis lethal toxin reduces human alveolar epithelial barrier function.
    Langer M; Duggan ES; Booth JL; Patel VI; Zander RA; Silasi-Mansat R; Ramani V; Veres TZ; Prenzler F; Sewald K; Williams DM; Coggeshall KM; Awasthi S; Lupu F; Burian D; Ballard JD; Braun A; Metcalf JP
    Infect Immun; 2012 Dec; 80(12):4374-87. PubMed ID: 23027535
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of lethal toxin and edema toxin to the pathogenesis of anthrax meningitis.
    Ebrahimi CM; Sheen TR; Renken CW; Gottlieb RA; Doran KS
    Infect Immun; 2011 Jul; 79(7):2510-8. PubMed ID: 21518787
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of either lethal toxin or edema toxin by Bacillus anthracis is sufficient for virulence in a rabbit model of inhalational anthrax.
    Lovchik JA; Drysdale M; Koehler TM; Hutt JA; Lyons CR
    Infect Immun; 2012 Jul; 80(7):2414-25. PubMed ID: 22526673
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of antibodies to Bacillus anthracis and anthrax toxin components in inhibiting the early stages of infection by anthrax spores.
    Welkos S; Little S; Friedlander A; Fritz D; Fellows P
    Microbiology (Reading); 2001 Jun; 147(Pt 6):1677-1685. PubMed ID: 11390699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine innate immune response to virulent toxigenic and nontoxigenic Bacillus anthracis strains.
    Drysdale M; Olson G; Koehler TM; Lipscomb MF; Lyons CR
    Infect Immun; 2007 Apr; 75(4):1757-64. PubMed ID: 17242059
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Revisiting the Concept of Targeting Only Bacillus anthracis Toxins as a Treatment for Anthrax.
    Glinert I; Bar-David E; Sittner A; Weiss S; Schlomovitz J; Ben-Shmuel A; Mechaly A; Altboum Z; Kobiler D; Levy H
    Antimicrob Agents Chemother; 2016 Aug; 60(8):4878-85. PubMed ID: 27270276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Toxin-deficient mutants of Bacillus anthracis are lethal in a murine model for pulmonary anthrax.
    Heninger S; Drysdale M; Lovchik J; Hutt J; Lipscomb MF; Koehler TM; Lyons CR
    Infect Immun; 2006 Nov; 74(11):6067-74. PubMed ID: 16923785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel live attenuated anthrax spore vaccine based on an acapsular Bacillus anthracis Sterne strain with mutations in the htrA, lef and cya genes.
    Chitlaru T; Israeli M; Rotem S; Elia U; Bar-Haim E; Ehrlich S; Cohen O; Shafferman A
    Vaccine; 2017 Oct; 35(44):6030-6040. PubMed ID: 28342664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human monoclonal antibody AVP-21D9 to protective antigen reduces dissemination of the Bacillus anthracis Ames strain from the lungs in a rabbit model.
    Peterson JW; Comer JE; Baze WB; Noffsinger DM; Wenglikowski A; Walberg KG; Hardcastle J; Pawlik J; Bush K; Taormina J; Moen S; Thomas J; Chatuev BM; Sower L; Chopra AK; Stanberry LR; Sawada R; Scholz WW; Sircar J
    Infect Immun; 2007 Jul; 75(7):3414-24. PubMed ID: 17452469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacillus anthracis spore movement does not require a carrier cell and is not affected by lethal toxin in human lung models.
    Booth JL; Duggan ES; Patel VI; Langer M; Wu W; Braun A; Coggeshall KM; Metcalf JP
    Microbes Infect; 2016 Oct; 18(10):615-626. PubMed ID: 27320392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Significant passive protective effect against anthrax by antibody to Bacillus anthracis inactivated spores that lack two virulence plasmids.
    Enkhtuya J; Kawamoto K; Kobayashi Y; Uchida I; Rana N; Makino SI
    Microbiology (Reading); 2006 Oct; 152(Pt 10):3103-3110. PubMed ID: 17005989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anthrax lethal toxin impairs innate immune functions of alveolar macrophages and facilitates Bacillus anthracis survival.
    Ribot WJ; Panchal RG; Brittingham KC; Ruthel G; Kenny TA; Lane D; Curry B; Hoover TA; Friedlander AM; Bavari S
    Infect Immun; 2006 Sep; 74(9):5029-34. PubMed ID: 16926394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Very Early Blood Diffusion of the Active Lethal and Edema Factors of Bacillus anthracis After Intranasal Infection.
    Rougeaux C; Becher F; Goossens PL; Tournier JN
    J Infect Dis; 2020 Feb; 221(4):660-667. PubMed ID: 31574153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of anthrax toxins in dissemination, disease progression, and induction of protective adaptive immunity in the mouse aerosol challenge model.
    Loving CL; Khurana T; Osorio M; Lee GM; Kelly VK; Stibitz S; Merkel TJ
    Infect Immun; 2009 Jan; 77(1):255-65. PubMed ID: 18955474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Screening of full human anthrax lethal factor neutralizing antibody in transgenic mice].
    Wang X; Chi X; Liu J; Liu W; Liu S; Qiu S; Wen Z; Fan P; Liu K; Song X; Fu L; Zhang J; Yu C
    Sheng Wu Gong Cheng Xue Bao; 2016 Nov; 32(11):1590-1599. PubMed ID: 29034628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Discriminating virulence mechanisms among Bacillus anthracis strains by using a murine subcutaneous infection model.
    Chand HS; Drysdale M; Lovchik J; Koehler TM; Lipscomb MF; Lyons CR
    Infect Immun; 2009 Jan; 77(1):429-35. PubMed ID: 18981254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MyD88-dependent signaling protects against anthrax lethal toxin-induced impairment of intestinal barrier function.
    Okugawa S; Moayeri M; Eckhaus MA; Crown D; Miller-Randolph S; Liu S; Akira S; Leppla SH
    Infect Immun; 2011 Jan; 79(1):118-24. PubMed ID: 20974827
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Zeptomole per milliliter detection and quantification of edema factor in plasma by LC-MS/MS yields insights into toxemia and the progression of inhalation anthrax.
    Lins RC; Boyer AE; Kuklenyik Z; Woolfitt AR; Goldstein J; Hoffmaster AR; Gallegos-Candela M; Leysath CE; Chen Z; Brumlow JO; Quinn CP; Bagarozzi DA; Leppla SH; Barr JR
    Anal Bioanal Chem; 2019 May; 411(12):2493-2509. PubMed ID: 30911800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.